Cyient Faces Persistent Revenue and Margin Challenges A Look Ahead Oramed Pharmaceuticals Inc ORMP Q4 2025 Earnings Surprise Profitability on Milestone Revenue Angeion Class Action Administrator Bans Vendor Rebates Amid Kickback Scrutiny